Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cutera, Inc. (CUTR)

49.66   -0.37 (-0.74%) 12-07 16:00
Open: 49.29 Pre. Close: 50.03
High: 50.789 Low: 48.63
Volume: 322,588 Market Cap: 974(M)

Technical analysis

as of: 2022-12-07 4:21:24 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 61.77     One year: 72.15
Support: Support1: 44.67    Support2: 39.59
Resistance: Resistance1: 52.88    Resistance2: 61.77
Pivot: 45.76
Moving Average: MA(5): 50.52     MA(20): 45.09
MA(100): 46.41     MA(250): 45.7
MACD: MACD(12,26): 1.4     Signal(9): 0.5
Stochastic oscillator: %K(14,3): 82.2     %D(3): 89
RSI: RSI(14): 60.8
52-week: High: 74.37  Low: 31.62
Average Vol(K): 3-Month: 285 (K)  10-Days: 256 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CUTR ] has closed below upper band by 22.9%. Bollinger Bands are 66.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.84 - 51.12 51.12 - 51.35
Low: 47.97 - 48.31 48.31 - 48.59
Close: 49.14 - 49.67 49.67 - 50.11

Company Description

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

Headline News

Wed, 07 Dec 2022
Cutera Plans $100 Million Offering of 2029 Convertible Notes; Shares Slump After-Hours -

Wed, 07 Dec 2022
After-hours movers: Rent the Runway jumps on guidance, HashiCorp gains on EPS By -

Wed, 07 Dec 2022
Cutera (CUTR) Announces Proposed Private Offering of $100 Million of Convertible Senior Notes -

Wed, 07 Dec 2022
Insiders who bought Cutera, Inc. (NASDAQ:CUTR) last year must be regretting not buying more as market cap hits US$981m - Simply Wall St

Thu, 01 Dec 2022
Cutera, Inc. Provides Response To FDA Inquiry - Cutera (NASDAQ:CUTR) - Benzinga

Thu, 01 Dec 2022
Cutera, Inc. Provides Response to FDA Inquiry - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 20 (M)
Shares Float 14 (M)
% Held by Insiders 2.5 (%)
% Held by Institutions 130.4 (%)
Shares Short 4,460 (K)
Shares Short P.Month 4,730 (K)

Stock Financials

EPS -0.71
EPS Est Next Qtl 0.34
EPS Est This Year 0.51
EPS Est Next Year 0.76
Book Value (p.s.) 0.79
Profit Margin (%) -31.4
Operating Margin (%) -13.8
Return on Assets (ttm) -6.2
Return on Equity (ttm) -221.7
Qtrly Rev. Growth 9.5
Gross Profit (p.s.) 6.78
Sales Per Share 12.77
EBITDA (p.s.) -1.67
Qtrly Earnings Growth 0
Operating Cash Flow -47 (M)
Levered Free Cash Flow -19 (M)

Stock Valuations

PE Ratio -69.95
PEG Ratio -1.8
Price to Book value 62.86
Price to Sales 3.88
Price to Cash Flow -20.6

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.